Diagnostic value of serum TGF-β1 and CysC in type 2 diabetic kidney disease: a cross-sectional study
CysC and TGF-β1 can serve as potential biomarkers for assessing renal impairment and proteinuria in T2DM patients. Their combined evaluation demonstrates diagnostic value and clinical application potential.
Authors
- Jin Qian (ORCID: https://orcid.org/0000-0002-9368-387X)
- Mengqi Zhou
- Yi Kang (ORCID: https://orcid.org/0000-0002-0166-0823)
- Huijuan Zheng (ORCID: https://orcid.org/0000-0002-8394-0844)
- Yaoxian Wang (ORCID: https://orcid.org/0000-0002-1927-9529)
- Xiaobin Li (ORCID: https://orcid.org/0000-0002-1099-6046)
- Jing Zhou (ORCID: https://orcid.org/0000-0003-2565-9103)
- Aoshuang Li
- Jie Lv
Institutions
- Beijing University of Chinese Medicine (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
- Beijing Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-04-11
- DOI
- https://doi.org/10.3389/fmed.2025.1529648
- Citations
- 2
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- National Natural Science Foundation of China